HealthNew Cancer Immunotherapy Approach Shows Promise Against Solid TumorsA personalized mRNA cancer vaccine combined with checkpoint inhibitors shrinks tumors in 78% of late-stage patients in early trials.Dr. Linda Nakamura//Apr 20, 2026//8m